Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times
Yıl: 2020 Cilt: 40 Sayı: 2 Sayfa Aralığı: 220 - 227 Metin Dili: İngilizce DOI: 10.5336/medsci.2020-75702 İndeks Tarihi: 25-12-2020
Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times
Öz: Objective: In December 2019, the new coronavirus(COVID-19), which is identified as a new pneumonia factor,emerged in Wuhan, China's Hubei province. The new coronavirus israpidly spreading all over the world and considered a pandemic. Thefirst case in Turkey was confirmed on March 10, 2020, and on March18, 2020, Turkey has reached the 100th case. Material and Methods:In this study, the doubling times of the outbreak in the EuropeanUnion countries, especially Turkey, were investigated.Moreover, in this context, as South Korea has been extensively testingboth symptomatic and asymptomatic patients and implementingeffective strategies, the doubling times have increased steadily linearlywithout any decline. Therefore, the doubling times for Europeancountries have been compared to South Korea. Results: Thehighest slope in doubling times was achieved in South Korea andAustria. Among the compared countries, Italy, despite its 51st dayafter its 100th case, has not yet experienced a rapid rise. In Turkey,the doubling time after the 100th case was calculated to be 1.04. Initially,Turkey was ranked as the country with the lowest doublingtimes between European Union countries, however, at the pointreached today (the 34th day after than the 100th case); after Spain,Austria, Switzerland, and South Korea, Turkey ranks fourth by adoubling time of 13.14. Conclusion: Turkey on the 34th day after the100th case of the outbreak, has made further successful progress morethan major European countries. The prolongation of the doublingtime in this wise is promising to combat the pandemic successfully.
Anahtar Kelime: Yeni Koronavirüs (COVID-19) Salgınında Türkiye ve Avrupa Birliği Ülkelerinin Karşılaştırması; İki Katına Çıkma Sürelerinin İncelenmesi
Öz: Amaç: Aralık 2019'da, Çin'in Hubei eyaleti olan Wuhan'da, yeni bir pnömoni etkeni olarak tanımlanan yeni koronavirüs (COVID- 19) ortaya çıktı. Yeni koronavirüs hızla tüm dünyaya yayıldı ve bir salgın olarak kabul edildi. Türkiye’de ilk vaka 10 Mart 2020’de doğrulanmış ve 18 Mart 2020’de 100’üncü vakaya ulaşılmıştır. Gereç ve Yöntemler: Bu çalışmada Avrupa Birliği ülkeleri, özellikle Türkiye’de, salgının iki katına çıkma süreleri incelenmiştir. Ayrıca bu bağlamda, Güney Kore, hem semptomatik hem de asemptomatik hastalara yoğun bir şekilde test yaptığı ve hasta takibi gibi etkili stratejiler uygulaması nedeniyle, iki katına çıkma süreleri herhangi bir düşüş yaşamadan, istikrarlı bir şekilde doğrusal olarak artmıştır. Bu nedenle Avrupa ülkeleri için iki katına çıkma süreleri Güney Kore ile karşılaştırılmıştır. Bulgular: İki katına çıkma sürelerinde en yüksek eğim Güney Kore ve Avusturya’da elde edilmiştir. Karşılaştırılan ülkeler arasında İtalya, 100’üncü vakasından sonra 51’inci gününde henüz hızlı bir yükselme yaşamamıştır. Türkiye ise sabit bir artış ile devam etmektedir. Türkiye’de 100’üncü vakadan sonra ilk iki katına çıkma süresi 1,04 olarak hesaplanmıştır. Başlangıçta Türkiye’de vakaların hızlı artışı ile iki katına çıkma süresi en düşük ülke konumundayken, bugün gelinen noktada (100’üncü vakasından sonra 34’üncü gün) İspanya, Avusturya, İsviçre, Güney Kore’den sonra, 13,14 iki katına çıkma süresi ile dördüncü sıradadır. Sonuç: Türkiye salgının 100’üncü vakasından sonra 34’üncü gününde beş büyük Avrupa ülkesinden daha başarılı ilerlemeler kaydetmiştir. İki katına çıkma sürelerini uzaması pandemi ile mücadelede başarı konusunda umut vaat edicidir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report- 89. World Health Organization; 2020. p.13. Cited April 19, 2020. [Link]
- 2. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92(4):401-2. [Crossref] [PubMed] [PMC]
- 3. World Health Organization (WHO). Naming the coronavirus disease (covid-19) and the virus that causes it. 2020. [Link]
- 4. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-6. [Crossref] [PubMed] [PMC]
- 5. Kassema JJ. COVID-19 Outbreak: is it a health crisis or economic crisis or both? Case of African counties. Case of African Counties. 2020;9(51):16. [Crossref]
- 6. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395 (10223):514-23. [Crossref] [PubMed]
- 7. do Nascimento B, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Novel coronavirus (2019-nCoV) infection in humans: a scoping review and meta-analysis. J Clin Med. 2020;9(4):E941. [PubMed]
- 8. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. [Crossref] [PubMed]
- 9. Pellis L, Scarabel F, Stage HB, Overton CE, Chappell LH, Lythgoe KA, et al. Challenges in control of Covid-19: short doubling time and long delay to effect of interventions. Cornell University. 2020. [Crossref]
- 10. Türkiye Bilimleri Akademisi. COVID-19 Pandemi Değerlendirme Raporu. TÜBA Raporları No:34. Ankara: Türkiye Bilimler Akademisi Yayınları; 2020. p.175.
- 11. Anderson RM, Anderson B, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press; 1992. p.757.
- 12. Galvani AP, Lei X, Jewell NP. Temporal stability and geographic variation in cumulative case fatality rates and average doubling times of SARS epidemics. Collection of Biostatistics Research Archive; 2003. [Crossref] [PubMed] [PMC]
- 13. Vynnycky E, White R. An Introduction to Infectious Disease Modelling. Oxford: OUP Oxford; 2010. p.370.
- 14. Weon BM. Doubling time tells how effective Covid-19 prevention works. MedRxiv. 30 March 2020. [Crossref]
- 15. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441-7. [Crossref] [PubMed] [PMC]
- 16. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27(2):taaa020. [Crossref] [PubMed] [PMC]
- 17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [Crossref] [PubMed]
- 18. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report- 86. World Health Organization; 2020. p.13.
- 19. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9. [Crossref] [PubMed] [PMC]
- 20. Wynants L, Van Calster B, Bonten MM, Collins GS, Debray TP, De Vos M, et al. Prediction models for diagnosis and prognosis of covid- 19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. [Crossref] [PubMed] [PMC]
- 21. Normile D. Coronavirus cases have dropped sharply in South Korea. What’s the secret to its success. Science. 2020;17(03). [Crossref]
| APA | Ahmadian R, uncu y, Ercan I (2020). Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. , 220 - 227. 10.5336/medsci.2020-75702 |
| Chicago | Ahmadian Robab,uncu yesim,Ercan Ilker Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. (2020): 220 - 227. 10.5336/medsci.2020-75702 |
| MLA | Ahmadian Robab,uncu yesim,Ercan Ilker Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. , 2020, ss.220 - 227. 10.5336/medsci.2020-75702 |
| AMA | Ahmadian R,uncu y,Ercan I Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. . 2020; 220 - 227. 10.5336/medsci.2020-75702 |
| Vancouver | Ahmadian R,uncu y,Ercan I Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. . 2020; 220 - 227. 10.5336/medsci.2020-75702 |
| IEEE | Ahmadian R,uncu y,Ercan I "Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times." , ss.220 - 227, 2020. 10.5336/medsci.2020-75702 |
| ISNAD | Ahmadian, Robab vd. "Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times". (2020), 220-227. https://doi.org/10.5336/medsci.2020-75702 |
| APA | Ahmadian R, uncu y, Ercan I (2020). Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. Türkiye Klinikleri Tıp Bilimleri Dergisi, 40(2), 220 - 227. 10.5336/medsci.2020-75702 |
| Chicago | Ahmadian Robab,uncu yesim,Ercan Ilker Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. Türkiye Klinikleri Tıp Bilimleri Dergisi 40, no.2 (2020): 220 - 227. 10.5336/medsci.2020-75702 |
| MLA | Ahmadian Robab,uncu yesim,Ercan Ilker Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. Türkiye Klinikleri Tıp Bilimleri Dergisi, vol.40, no.2, 2020, ss.220 - 227. 10.5336/medsci.2020-75702 |
| AMA | Ahmadian R,uncu y,Ercan I Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2020; 40(2): 220 - 227. 10.5336/medsci.2020-75702 |
| Vancouver | Ahmadian R,uncu y,Ercan I Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2020; 40(2): 220 - 227. 10.5336/medsci.2020-75702 |
| IEEE | Ahmadian R,uncu y,Ercan I "Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times." Türkiye Klinikleri Tıp Bilimleri Dergisi, 40, ss.220 - 227, 2020. 10.5336/medsci.2020-75702 |
| ISNAD | Ahmadian, Robab vd. "Turkey in Between European Union Countries in the New Coronavirus (COVID-19) Outbreak; An Examination of the Doubling Times". Türkiye Klinikleri Tıp Bilimleri Dergisi 40/2 (2020), 220-227. https://doi.org/10.5336/medsci.2020-75702 |
